1-Bromo-3-phenoxybenzene, 95.0%, 1g

Ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate, 98+%, 1g

3-(Oxazol-4-yl)aniline, 95.0%, 5g

ZEOprep 60A/60-200, 25kg

(R)-1-m-Tolylethanamine, 95.0%, 10g

Ethyl 3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propanoate, 95.0%, 250mg

(R)-Butan-2-amine hydrochloride, 97%, 1g

1-Benzyl-4-bromo-1,2,3,6-tetrahydropyridine, 95.0%, 250mg

P-XYLYLENEDIPHOSPHONIC ACID, 97%, 5g

Closing caps, Gesch. front, Ø 18 mm 1000 pcs

2,2,2-Trifluoro-N-phenylacetimidoyl Chloride>98.0%(GC)(T)25g

4-(Trifluoromethyl)pyrimidine-2-carbaldehyde, 98%, 250mg

N-DBCO-N-bis(PEG2-C2-NHS ester), 50mg